跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CITANEST 2% POLYAMP DUOFIT prilocaine hydrochloride 100mg/5mL injection BP ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
CITANEST 2% POLYAMP DUOFIT prilocaine hydrochloride 100mg/5mL injection BP ampoule
Approved
STANDARD
CITANEST 2% POLYAMP DUOFIT prilocaine hydrochloride 100mg/5mL injection BP ampoule
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4a2664af2cf3ec9f
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4a2664af2cf3ec9f
Product Name
CITANEST 2% POLYAMP DUOFIT prilocaine hydrochloride 100mg/5mL injection BP ampoule
Artg Id
53722
Artg Name
CITANEST 2% POLYAMP DUOFIT prilocaine hydrochloride 100mg/5mL injection BP ampoule
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1996-05-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/ee8bc10ee248c31360e0a328102712b8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4a2664af2cf3ec9f
Type
Standard
Back to TGA Approvals